PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
22-Oct-2024 Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing AccessWire
22-Oct-2024 UKs Largest Medical Cannabis Deal Signed by Releaf AccessWire
22-Oct-2024 Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing Newswire
22-Oct-2024 Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis Immunic AG
22-Oct-2024 NanoViricides President Dr. Diwan to Present at the PODD Conference AccessWire
22-Oct-2024 Genflow Secures Non-Dilutive Financial Support AccessWire
22-Oct-2024 Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates Lonza Group AG
22-Oct-2024 CD Formulation Offers Custom MOF Development Services for Precise Antibody Drug Delivery CD Formulation
22-Oct-2024 Alfa Chemistry Newly Releases In-Stock Main Products: Excellence in Every Product Alfa Chemistry
22-Oct-2024 Alfa Chemistry Announces Launch of Polymer Optical Fibers, Pitch-Based Carbon Fibers, Chitin and Chitosan Fibers Alfa Chemistry
22-Oct-2024 AI/ML Innovations Inc. Announces Proposed Private Placement AccessWire
21-Oct-2024 Justera Health Announces Closing of Debt Settlement Agreement AccessWire
21-Oct-2024 Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences AccessWire
21-Oct-2024 Legacy ER & Urgent Care Prosper Now Open AccessWire
21-Oct-2024 Medacta unveils the extended enhancements to its Hip Revision Platform Medacta Group SA
21-Oct-2024 HER2 Positive Gastric Cancer Market is expected to be valued at USD 1779.8 million by 2033, at a CAGR of 3.5% MARKITWIRED
21-Oct-2024 Malignant Pleural Effusion Market value of USD 8.06 Billion by Registering a CAGR of 6% by 2033 MARKITWIRED
21-Oct-2024 Acrometa Group to Divest Its Life Sciences Business, Pursue New Business Opportunities in the Region AcroMeta Group Limited
21-Oct-2024 Global Parkinson’s Disease Market Set for USD 6.7 Billion Valuation, Powered by a 5.1% CAGR, from 2024 to 2034 MARKITWIRED
21-Oct-2024 Oncolytic Adenovirus Market Targets USD 250 Billion Valuation by 2033 at a 7.5% of CAGR MARKITWIRED